EG-110A

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameEG-110A
Drug Alias NameEG-110AEG110A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Herpes simplex virus vector > HSV-1 vector
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsUrinary Bladder, OveractiveCystitis, InterstitialUrologic Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEG 427 Inc
China Registration ClassN/A

Develop Information

Active CompaniesEG 427 Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder, OveractiveCystitis, InterstitialUrologic Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A